Crosslinking to help a KPro eye resist corneal melting
Part of Eyes & vision clinical trials.
This trial tests a treatment called corneal collagen crosslinking to strengthen the tissue under a KPro type I (an artificial cornea). It may help reduce the risk of corneal melting in people who need a KPro.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being considered for a KPro type I (artificial cornea).
- You can read, understand, and sign a written consent form.
- You can come to study visits and be followed for the whole study period.
- You are not currently in another treatment study at the same time.
- You can wear the needed therapeutic contact lens as instructed.
- Your eye conditions don’t include the listed KPro type I contraindications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a specific eye laser treatment done through the white of the eye (called transscleral cyclophotocoagulation) works well and is safe for people getting a Boston keratoprosthesis. It may help improve comfort and vision outcomes for selected patients needing this type of cornea/eye replacement surgery.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study tests a lab-grown (ex vivo) method of strengthening donor cornea tissue used in cornea transplants for people with keratoconus. It may help improve how well the transplanted cornea heals and functions.
This study tests a same-day procedure that strengthens the cornea (the clear front part of the eye) in both eyes using a special light treatment, called cross-linking. It may help slow or stop the progression of keratoconus, a condition where the cornea becomes cone-shaped and causes blurry vision.
This trial tests a new artificial cornea device (keratoprosthesis) for people with severe corneal scarring or damage who cannot see well and are at high risk for corneal transplant failure. The goal is to restore vision and improve quality of life.
This trial studies corneal crosslinking to treat active inflammation or infection that leads to new blood vessels growing into the cornea. It may help reduce ongoing damage and lower the risk of problems, including issues that can threaten a future corneal transplant.
Hear when a new Corneal Melting in Boston Keratoprosthesis Type I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.